German Breast Group

The German Breast Group (GBG) Research GmbH is an academic research organisation with 90 employees specialised in the implementation of investigator-initiated trials of malignant breast cancer, providing the platform for all clinical studies of the German Breast Group. This academic research institute has recruited up to 4250 patients annually in clinical breast cancer trials. The GBG is currently conducting 18 breast cancer trials, in 10 of those GBG is the legal sponsor of the study. GBG covers the complete portfolio to conduct large scale phase III studies including protocol development, monitoring, data-management and statistics.


GBG will provide clinical user requirements, clinical knowledge based on the group‘s outstanding expertise in running clinical trials, clinical data, and all needed technical information on its clinical information systems in a non-academic but highly specialised centre in Germany. GBG will also contribute to the dissemination of the project‘s results within their large network and to the evaluation and validation of the data.